Stocks · Health care · Pharmaceutical Preparations

Kiniksa Pharmaceuticals International, plc

KNSA Clue Score67
Fiscal year ends December CIK 0001730430 Results filed 27 Oct 2026

What the insiders did Mostly scheduled

Insider
Date
Role
Action
Shares
Price
Amount
Michael R Megna
3 Sep 2026
Chief Accounting Officer
Sold on a plan
4,600
$80.30
$369.38K
Ross Moat
9 Apr 2026
Chief Operating Officer
Sold on a plan
1,703
$46.69
$79.51K
Michael R Megna
9 Apr 2026
Chief Accounting Officer
Sold on a plan
6,625
$46.69
$309.32K
Ross Moat
6 Apr 2026
Chief Operating Officer
Sold on a plan
2,367
$48.58
$114.99K
Mark Ragosa
8 Jan 2026
Chief Financial Officer
Sold on a plan
12,000
$41.89
$502.68K

What was left out

Form 4 filings counted 56
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 78
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 2,865,665
History held since 29 May 2018